...
首页> 外文期刊>Journal of Analytical Toxicology >Evaluation of Intraosseous Fluid as an Alternative Biological Specimen in Postmortem Toxicology
【24h】

Evaluation of Intraosseous Fluid as an Alternative Biological Specimen in Postmortem Toxicology

机译:骨髓内液评价为术后毒理学中的替代生物标本

获取原文
获取原文并翻译 | 示例

摘要

The postmortem redistribution phenomenon is an important factor in the interpretation of blood drug concentrations as a cause or factor in death. Intraosseous fluid (IOF) may serve as an alternative matrix for drug testing. Intraosseous fluid was collected from the left and right tibias and humerus of 29 decedents using the Arrow EZ-IO Intraosseous Vascular Access System. Standard autopsy specimens including blood were also collected at the same time during autopsy. Blood and IOF specimens were screened by immunoassay for opioids, fentanyl analogs, oxycodone, methadone, cocaine, methamphetamine, amphetamines, phencyclidine, tricyclic antidepressants, benzodiazepines and cannabinoids, using commercially available enzyme-linked immunosorbent assay (ELISA) kits. Correlation between cardiac/central blood ELISA and IOF ELISA results was mostly 100% for drug targets. Further blood confirmation analysis was performed by gas chromatography mass spectrometry also showed comparable correlation to IOF screen results. There was no significant difference between the IOF sites or sides of the body. This novel study supports the use of IOF as an alternative postmortem specimen for toxicological investigations as a potentially less-compromised tissue in decomposed or traumatized bodies. Preliminary data is provided for the screening of common drugs of abuse in IOF that may show to be subject to alternative rates of postmortem redistribution than to that of other biological specimens in future studies that quantitate IOF drug concentrations.
机译:淘汰后的再分布现象是将血液药物浓度解释为死亡或因素的重要因素。骨质液(IOF)可以用作药物检测的替代基质。使用箭头EZ-IO骨内血管接入系统从左右胫骨和右侧胫骨和肱骨Humerus收集骨质液。在尸检期间也在包括血液的标准尸检标本。使用市售的酶联免疫吸附测定(ELISA)试剂盒,通过用于阿片类药物,芬太尼,羟基酮,甲基,可卡因,三环抗抑郁药,苯并二氮杂噻吩,苯二氮卓和大麻素,筛选血液和IOF标本。心脏/中枢血液ELISA与IOF ELISA结果之间的相关性主要是药物目标的100%。通过气相色谱质谱法进行进一步的血液确认分析也显示出与IOF筛选结果的相当相关性。 IOF网站或身体的侧面之间没有显着差异。该新型研究支持使用IOF作为替代毒理学调查的标本,作为毒理学调查,作为分解或创伤体内的潜在较低的组织。提供初步数据用于筛选IOF中的滥用常见药物,其可能表现出在未来的研究中的替代率被再分布的替代率,而不是定量IOF药物浓度的未来研究中的其他生物标本。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号